| New approaches to drug selection and serial drug testing. | |
| | |
MedLine Citation:
|
PMID: 6207209 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Sudden cardiac death is a major problem in the United States. Our goal is to identify high-risk patients and to be able to target antiarrhythmic therapy to this population. Ambulatory electrocardiography, exercise tolerance testing, and programmed electrical stimulation studies may aid in the identification of patients at risk for sudden cardiac death and the selection of antiarrhythmic therapy. Each technique has its advantages, disadvantages, and limitations. These considerations must be taken into account if the procedure is to be optimally employed. We are in a period of rapid development of new antiarrhythmic agents. It is essential to fully understand the techniques employed to evaluate antiarrhythmic therapy. |
| | |
Authors:
|
J C Somberg |
Related Documents
:
|
7149099 - An onchocercal nodule appearing during diethylcarbamazine therapy. 1470709 - The benefits of exercise combined with physiotherapy in the treatment of adults with cy... 18829599 - A systematic review of exercise interventions in patients with heart failure. 20333769 - Exercise as a supportive therapy in incurable cancer: exploring patient preferences. 11567539 - Lifestyle changes in the management of osteoarthritis. 19744419 - Clinical inquiries. how should you treat trochanteric bursitis? 18755679 - Moving with the beat: heart rate and visceral temperature of free-swimming and feeding ... 9277379 - Fatty acid oxidation is directly regulated by carbohydrate metabolism during exercise. 16176379 - Airways, respiration, and respiratory sinus arrhythmia during picture viewing. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of clinical pharmacology Volume: 24 ISSN: 0091-2700 ISO Abbreviation: J Clin Pharmacol Publication Date: 1984 Jul |
Date Detail:
|
Created Date: 1984-11-19 Completed Date: 1984-11-19 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0366372 Medline TA: J Clin Pharmacol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 320-7 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-Arrhythmia Agents
/
adverse effects,
therapeutic use* Arrhythmias, Cardiac / drug therapy, etiology, physiopathology* Cardiac Complexes, Premature / mortality Coronary Disease / physiopathology Death, Sudden / prevention & control Electric Stimulation Electrocardiography Exercise Test Humans Monitoring, Physiologic Risk Tachycardia / physiopathology |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Arrhythmia Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of hydroxyethyl starch and dextran on plasma volume and blood hemostasis and coagulation.
Next Document: Hypomyelination in the peripheral nervous system of shiverer mice and in shiverer in equilibrium nor...